JNJ vs. ISRG, MRNA, NVAX, ABBV, BRK.B, LLY, MRK, PFE, PG, and XOM
Should you be buying Johnson & Johnson stock or one of its competitors? The main competitors of Johnson & Johnson include Intuitive Surgical (ISRG), Moderna (MRNA), Novavax (NVAX), AbbVie (ABBV), Berkshire Hathaway (BRK.B), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), Pfizer (PFE), Procter & Gamble (PG), and Exxon Mobil (XOM).
Johnson & Johnson vs. Its Competitors
Intuitive Surgical (NASDAQ:ISRG) and Johnson & Johnson (NYSE:JNJ) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.
83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 69.6% of Johnson & Johnson shares are held by institutional investors. 0.7% of Intuitive Surgical shares are held by company insiders. Comparatively, 0.2% of Johnson & Johnson shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Johnson & Johnson has higher revenue and earnings than Intuitive Surgical. Johnson & Johnson is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Intuitive Surgical has a net margin of 28.51% compared to Johnson & Johnson's net margin of 25.00%. Johnson & Johnson's return on equity of 32.49% beat Intuitive Surgical's return on equity.
Intuitive Surgical currently has a consensus price target of $595.95, indicating a potential upside of 37.32%. Johnson & Johnson has a consensus price target of $176.29, indicating a potential downside of 0.68%. Given Intuitive Surgical's higher possible upside, research analysts clearly believe Intuitive Surgical is more favorable than Johnson & Johnson.
Intuitive Surgical has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, Johnson & Johnson has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500.
In the previous week, Johnson & Johnson had 53 more articles in the media than Intuitive Surgical. MarketBeat recorded 110 mentions for Johnson & Johnson and 57 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 1.34 beat Johnson & Johnson's score of 1.34 indicating that Intuitive Surgical is being referred to more favorably in the media.
Summary
Intuitive Surgical beats Johnson & Johnson on 9 of the 17 factors compared between the two stocks.
Get Johnson & Johnson News Delivered to You Automatically
Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding JNJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Johnson & Johnson Competitors List
Related Companies and Tools
This page (NYSE:JNJ) was last updated on 9/15/2025 by MarketBeat.com Staff
